Your browser doesn't support javascript.
loading
Vigabatrin Retinal Toxicity First Detected with Electroretinographic Changes: A Case Report.
Barrett, Dianne; Yang, Jin; Sujirakul, Tharikarn; Tsang, Stephen H.
Afiliação
  • Barrett D; College of Physicians & Surgeons, Columbia University, New York, NY 10032, USA.
  • Yang J; Edward S. Harkness Eye Institute, Columbia University, New York, NY 10032, USA.
  • Sujirakul T; Edward S. Harkness Eye Institute, Columbia University, New York, NY 10032, USA.
  • Tsang SH; Edward S. Harkness Eye Institute, Columbia University, New York, NY 10032, USA ; Bernard & Shirlee Brown Glaucoma Laboratory, Departments of Ophthalmology, Pathology & Cell Biology, Columbia University, New York, NY 10032, USA ; New York-Presbyterian Hospital/Columbia University Medical Cent
Article em En | MEDLINE | ID: mdl-26295007
ABSTRACT
Vigabatrin is an effective antiepileptic drug (AED) typically used in the treatment of refractory partial seizures and infantile spasms. Its use, however, is limited due to the concern of retinal toxicity and subsequent visual field defects. Herewith in we describe a case of vigabatrin toxicity that illustrates electroretinographic (ERG) changes occur before imaging and visual field deterioration. Decrease in maximal ERG b a ratio was observed before thinning of the retinal nerve fiber layer (RNFL) on optical coherence tomography (OCT).
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article